STAAR Surgical Profit Margin 2006-2019 | STAA

Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of September 30, 2019 is 6.15%.
STAAR Surgical Annual Profit Margins
STAAR Surgical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.662B $0.124B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.506B 22.32
McKesson (MCK) United States $25.635B 10.16
Align Technology (ALGN) United States $21.730B 59.55
AmerisourceBergen (ABC) United States $18.171B 12.46
Laboratory Of America Holdings (LH) United States $16.670B 15.65
Cardinal Health (CAH) United States $16.049B 10.43
Straumann Holding AG (SAUHF) Switzerland $15.257B 0.00
Cooper (COO) United States $15.229B 24.87
DENTSPLY SIRONA (XRAY) United States $12.911B 25.24
West Pharmaceutical Services (WST) United States $10.911B 46.82
Henry Schein (HSIC) United States $10.187B 18.97
CONMED (CNMD) United States $3.236B 45.97
Patterson (PDCO) United States $2.250B 16.67
Merit Medical Systems (MMSI) United States $1.609B 18.80
Atrion (ATRI) United States $1.310B 36.09
Antares Pharma (ATRS) United States $0.798B 489.00
Invacare (IVC) United States $0.310B 0.00
Lifevantage (LFVN) United States $0.213B 23.46
Pro-Dex (PDEX) United States $0.063B 17.07
Endologix (ELGX) United States $0.042B 0.00
Biolase (BIOL) United States $0.016B 0.00